The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

NCT02200354 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped inclusion speed

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

DRUG: pemetrexed with bevacizumab

Sponsor

Kobe City General Hospital